168 related articles for article (PubMed ID: 29207594)
1. Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Cao B; Fang Z; Liao P; Zhou X; Xiong J; Zeng S; Lu H
Oncotarget; 2017 Oct; 8(53):90651-90661. PubMed ID: 29207594
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
Del Toro N; Fernandez-Ruiz A; Mignacca L; Kalegari P; Rowell MC; Igelmann S; Saint-Germain E; Benfdil M; Lopes-Paciencia S; Brakier-Gingras L; Bourdeau V; Ferbeyre G; Lessard F
Cell Cycle; 2019; 18(6-7):759-770. PubMed ID: 30874462
[TBL] [Abstract][Full Text] [Related]
3. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
Elife; 2018 Mar; 7():. PubMed ID: 29547122
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
5. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
Zhou X; Hao Q; Liao J; Zhang Q; Lu H
Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
[TBL] [Abstract][Full Text] [Related]
7. Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of Gastric Cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (MDM2-p53) Signaling Pathway.
Sun Z; Qiu Z; Wang Z; Chi H; Shan P
Med Sci Monit; 2021 May; 27():e928375. PubMed ID: 34050122
[TBL] [Abstract][Full Text] [Related]
8. p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.
Jung JH; Lee H; Kim JH; Sim DY; Ahn H; Kim B; Chang S; Kim SH
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31022952
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
[TBL] [Abstract][Full Text] [Related]
10. Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation.
Zheng J; Lang Y; Zhang Q; Cui D; Sun H; Jiang L; Chen Z; Zhang R; Gao Y; Tian W; Wu W; Tang J; Chen Z
Genes Dev; 2015 Jul; 29(14):1524-34. PubMed ID: 26220995
[TBL] [Abstract][Full Text] [Related]
11. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
Wang B; Gao J; Zhao Z; Zhong X; Cui H; Hou H; Zhang Y; Zheng J; Di J; Liu Y
Mol Med; 2022 Sep; 28(1):109. PubMed ID: 36071402
[TBL] [Abstract][Full Text] [Related]
12. Structure of nascent 5S RNPs at the crossroad between ribosome assembly and MDM2-p53 pathways.
Castillo Duque de Estrada NM; Thoms M; Flemming D; Hammaren HM; Buschauer R; Ameismeier M; Baßler J; Beck M; Beckmann R; Hurt E
Nat Struct Mol Biol; 2023 Aug; 30(8):1119-1131. PubMed ID: 37291423
[TBL] [Abstract][Full Text] [Related]
13. Olaparib Induces RPL5/RPL11-Dependent p53 Activation
Han T; Tong J; Wang M; Gan Y; Gao B; Chen J; Liu Y; Hao Q; Zhou X
Front Oncol; 2022; 12():821366. PubMed ID: 35719981
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
[TBL] [Abstract][Full Text] [Related]
15. Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling.
Solanki NR; Stadanlick JE; Zhang Y; Duc AC; Lee SY; Lauritsen JP; Zhang Z; Wiest DL
J Immunol; 2016 Sep; 197(6):2280-9. PubMed ID: 27489283
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Tong D; Zhang J; Wang X; Li Q; Liu LY; Yang J; Guo B; Ni L; Zhao L; Huang C
Oncogenesis; 2020 Jun; 9(5):56. PubMed ID: 32483207
[TBL] [Abstract][Full Text] [Related]
17. Dual regulation of p53 by the ribosome maturation factor SBDS.
Hao Q; Wang J; Chen Y; Wang S; Cao M; Lu H; Zhou X
Cell Death Dis; 2020 Mar; 11(3):197. PubMed ID: 32198344
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Oršolić I; Bursać S; Jurada D; Drmić Hofman I; Dembić Z; Bartek J; Mihalek I; Volarević S
Oncogene; 2020 Apr; 39(17):3443-3457. PubMed ID: 32108164
[TBL] [Abstract][Full Text] [Related]
19. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint.
Fahl SP; Harris B; Coffey F; Wiest DL
J Immunol; 2015 Jan; 194(1):200-9. PubMed ID: 25416806
[TBL] [Abstract][Full Text] [Related]
20. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity.
Teng T; Mercer CA; Hexley P; Thomas G; Fumagalli S
Mol Cell Biol; 2013 Dec; 33(23):4660-71. PubMed ID: 24061479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
